{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:44:22Z","timestamp":1787240662282,"version":"build-2736575974"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["F4414"],"award-info":[{"award-number":["F4414"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["W1206-08"],"award-info":[{"award-number":["W1206-08"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Science Fund"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13311-022-01287-8","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T16:03:36Z","timestamp":1661184216000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Mouse Model of Multiple System Atrophy: Bench to Bedside"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-639X","authenticated-orcid":false,"given":"Nadia","family":"Stefanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-022-01287-8_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","article-title":"Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy","volume":"32","author":"Graham","year":"1969","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-022-01287-8_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-022-01287-8_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-022-01287-8_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1007\/s13311-022-01287-8_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(05)79256-4","article-title":"Multiple-system atrophy: a new alpha-synuclein disease?","volume":"352","author":"Gai","year":"1998","journal-title":"Lancet"},{"key":"10.1007\/s13311-022-01287-8_bib6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01287-8_bib7","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1007\/s13311-022-01287-8_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O'Sullivan","year":"2008","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01287-8_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-022-01287-8_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01287-8_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01287-8_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","article-title":"Clinicopathological study of 35 cases of multiple system atrophy","volume":"58","author":"Wenning","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-022-01287-8_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnen\/63.1.43","article-title":"Microglial activation parallels system degeneration in multiple system atrophy","volume":"63","author":"Ishizawa","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-022-01287-8_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1789.2007.00855.x","article-title":"Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: a quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system)","volume":"28","author":"Ishizawa","year":"2008","journal-title":"Neuropathology"},{"key":"10.1007\/s13311-022-01287-8_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0002-9440(10)65617-9","article-title":"Myelin degeneration in multiple system atrophy detected by unique antibodies","volume":"153","author":"Matsuo","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-022-01287-8_bib17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","article-title":"p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy","volume":"171","author":"Song","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-022-01287-8_bib18","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12640-011-9294-3","article-title":"Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model","volume":"21","author":"Stefanova","year":"2012","journal-title":"Neurotox Res"},{"key":"10.1007\/s13311-022-01287-8_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jnen\/nly090","article-title":"NLRP3 inflammasome-related proteins are upregulated in the putamen of patients with multiple system atrophy","volume":"77","author":"Li","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-022-01287-8_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12974-018-1339-6","article-title":"Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes","volume":"15","author":"Starhof","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-022-01287-8_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fncel.2019.00263","article-title":"Neuroinflammation and glial phenotypic changes in alpha-synucleinopathies","volume":"13","author":"Refolo","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-022-01287-8_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21465","article-title":"Multiple system atrophy: a primary oligodendrogliopathy","volume":"64","author":"Wenning","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-022-01287-8_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00401-003-0811-1","article-title":"Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy","volume":"107","author":"Nishie","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1007\/s13311-022-01287-8_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00310020","article-title":"Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy","volume":"83","author":"Arima","year":"1992","journal-title":"1. Neuronal cytoplasmic inclusions. Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1789.2006.00713.x","article-title":"Cellular pathology in multiple system atrophy","volume":"26","author":"Wakabayashi","year":"2006","journal-title":"Neuropathology"},{"key":"10.1007\/s13311-022-01287-8_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2003.09.075","article-title":"Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy","volume":"354","author":"Lin","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-022-01287-8_bib29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01287-8_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1007\/s13311-022-01287-8_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1007\/s13311-022-01287-8_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","article-title":"Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update","volume":"119","author":"Jellinger","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","article-title":"A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy","volume":"1326","author":"Bukhatwa","year":"2010","journal-title":"Brain Res"},{"key":"10.1007\/s13311-022-01287-8_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1440-1789.2011.01222.x","article-title":"Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course","volume":"32","author":"Masui","year":"2012","journal-title":"Neuropathology"},{"key":"10.1007\/s13311-022-01287-8_bib35","article-title":"AMBRA1, a novel alpha-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy","author":"Miki","year":"2016","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-022-01287-8_bib36","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","article-title":"Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia","volume":"112","author":"Miller","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-022-01287-8_bib37","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/glia.22653","article-title":"Alpha-synuclein mRNA expression in oligodendrocytes in MSA","volume":"62","author":"Asi","year":"2014","journal-title":"Glia"},{"key":"10.1007\/s13311-022-01287-8_bib38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","article-title":"Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models","volume":"5","author":"Djelloul","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1007\/s13311-022-01287-8_bib39","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","article-title":"Alpha-synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy","volume":"35","author":"May","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-022-01287-8_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1750-3639.2012.00637.x","article-title":"Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease","volume":"23","author":"Ahmed","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-022-01287-8_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-005-1029-1","article-title":"An autopsy case of early (\u201cminimal change\u201d) olivopontocerebellar atrophy (multiple system atrophy-cerebellar)","volume":"110","author":"Wakabayashi","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mds.26220","article-title":"Minimal change multiple system atrophy: an aggressive variant?","volume":"30","author":"Ling","year":"2015","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01287-8_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41531-021-00262-y","article-title":"Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's disease","volume":"7","author":"Vacchi","year":"2021","journal-title":"NPJ Parkinson's disease"},{"key":"10.1007\/s13311-022-01287-8_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-015-0208-0","article-title":"Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy","volume":"3","author":"Nakamura","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01287-8_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2019.102583","article-title":"Shrinkage of the myenteric neurons of the small intestine in patients with multiple system atrophy","volume":"221","author":"Ozawa","year":"2019","journal-title":"Autonomic neuroscience: basic & clinical"},{"key":"10.1007\/s13311-022-01287-8_bib47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0304-3940(99)00475-9","article-title":"No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy","volume":"270","author":"Ozawa","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-022-01287-8_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-9-44","article-title":"Analysis of COQ2 gene in multiple system atrophy","volume":"9","author":"Ogaki","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-022-01287-8_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2 in familial and sporadic multiple-system atrophy","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-022-01287-8_bib50","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01287-8_bib51","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mds.28338","article-title":"Shared genetics of multiple system atrophy and inflammatory bowel disease","volume":"36","author":"Shadrin","year":"2021","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib52","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.20303","article-title":"Case-control study of multiple system atrophy","volume":"20","author":"Vanacore","year":"2005","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mcn.2005.03.001","article-title":"Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death","volume":"29","author":"Tsuboi","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1007\/s13311-022-01287-8_bib54","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jnr.1171","article-title":"Glial cell death induced by overexpression of alpha-synuclein","volume":"65","author":"Stefanova","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-022-01287-8_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(02)00117-9","article-title":"Ultrastructure of alpha-synuclein-positive aggregations in U373 astrocytoma and rat primary glial cells","volume":"323","author":"Stefanova","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-022-01287-8_bib56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jnr.10662","article-title":"Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein","volume":"73","author":"Stefanova","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-022-01287-8_bib57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00401-019-02014-y","article-title":"Endogenous oligodendroglial alpha-synuclein and TPPP\/p25\u03b1 orchestrate alpha-synuclein pathology in experimental multiple system atrophy models","volume":"138","author":"Mavroeidi","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson's disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-022-01287-8_bib59","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.stemcr.2018.09.007","article-title":"Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy","volume":"11","author":"Monzio Compagnoni","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1007\/s13311-022-01287-8_bib60","doi-asserted-by":"crossref","first-page":"14215","DOI":"10.1038\/s41598-018-32573-1","article-title":"The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy","volume":"8","author":"Nakamoto","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-022-01287-8_bib61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/nan.12661","article-title":"Signs of early cellular dysfunction in multiple system atrophy","volume":"47","author":"Herrera-Vaquero","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1007\/s13311-022-01287-8_bib62","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mds.870110507","article-title":"Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration","volume":"11","author":"Wenning","year":"1996","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0306-4522(00)00171-8","article-title":"Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)","volume":"99","author":"Scherfler","year":"2000","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-022-01287-8_bib64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1531-8257(200005)15:3<531::AID-MDS1017>3.0.CO;2-C","article-title":"Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration","volume":"15","author":"Ghorayeb","year":"2000","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib65","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0306-4522(99)00457-1","volume":"95","author":"Puschban","year":"2000","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-022-01287-8_bib66","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57B1\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-022-01287-8_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-003-0717-y","article-title":"Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy)","volume":"106","author":"Stefanova","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1007\/s13311-022-01287-8_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism","author":"Prusiner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01287-8_bib69","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01287-8_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810093","article-title":"Is multiple system atrophy a prion-like disorder?","volume":"22","author":"Jellinger","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01287-8_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1007\/s13311-022-01287-8_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101166","article-title":"Propagation of pathological \u03b1-synuclein from the urogenital tract to the brain initiates MSA-like syndrome?","volume":"23","author":"Ding","year":"2020","journal-title":"iScience"},{"key":"10.1007\/s13311-022-01287-8_bib73","article-title":"Host oligodendrogliopathy and \u0251-synuclein strains dictate disease severity in multiple system atrophy","author":"Torre-Muruzabal","year":"2022","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01287-8_bib74","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-019-01959-4","article-title":"Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines","volume":"137","author":"Woerman","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib75","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1007\/s13311-022-01287-8_bib76","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","article-title":"Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy","volume":"25","author":"Shults","year":"2005","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-022-01287-8_bib77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","article-title":"Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration","volume":"45","author":"Yazawa","year":"2005","journal-title":"Neuron"},{"key":"10.1007\/s13311-022-01287-8_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","article-title":"Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies","volume":"6","author":"Refolo","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01287-8_bib79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.nbd.2019.03.020","article-title":"A mouse model of adult-onset multiple system atrophy","volume":"127","author":"Tanji","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-022-01287-8_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-017-0451-7","article-title":"Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates","volume":"5","author":"Mandel","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01287-8_bib81","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00401-020-02126-w","article-title":"T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease","volume":"139","author":"Williams","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105184","article-title":"Viral-based rodent and nonhuman primate models of multiple system atrophy: fidelity to the human disease","volume":"148","author":"Marmion","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-022-01287-8_bib83","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.27041","article-title":"Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy","volume":"32","author":"Bassil","year":"2017","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40478-021-01166-x","article-title":"Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy","volume":"9","author":"M\u00e9sz\u00e1ros","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01287-8_bib85","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","article-title":"Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy","volume":"166","author":"Stefanova","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-022-01287-8_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-012-0977-5","article-title":"Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy","volume":"124","author":"Stefanova","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mds.25336","article-title":"Bladder dysfunction in a transgenic mouse model of multiple system atrophy","volume":"28","author":"Boudes","year":"2013","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib88","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.expneurol.2013.02.002","article-title":"Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence","volume":"247","author":"Kuzdas","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-022-01287-8_bib89","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.expneurol.2010.05.008","article-title":"Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure","volume":"224","author":"Stemberger","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-022-01287-8_bib90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/mds.25804","article-title":"Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy","volume":"29","author":"Flabeau","year":"2014","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib91","first-page":"252","article-title":"Distinct parameters in the EEG of the PLP alpha-SYN mouse model for multiple system atrophy reinforce face validity","volume":"10","author":"Hartner","year":"2016","journal-title":"Front Behav Neurosci"},{"key":"10.1007\/s13311-022-01287-8_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064625","article-title":"Intact olfaction in a mouse model of multiple system atrophy","volume":"8","author":"Krismer","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01287-8_bib93","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3233\/JPD-213039","article-title":"Evolution of prodromal multiple system atrophy from REM sleep behavior disorder: a descriptive study","volume":"12","author":"Postuma","year":"2022","journal-title":"Journal of Parkinson's disease"},{"key":"10.1007\/s13311-022-01287-8_bib94","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.parkreldis.2020.10.003","article-title":"How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?","volume":"81","author":"Moscovich","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-022-01287-8_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150705","article-title":"Changes in the miRNA-mRNA regulatory network precede motor symptoms in a mouse model of multiple system atrophy: clinical implications","volume":"11","author":"Schafferer","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01287-8_bib96","volume":"2","author":"Dickson","year":"2012","journal-title":"Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med"},{"key":"10.1007\/s13311-022-01287-8_bib97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00401-016-1572-y","article-title":"Alpha-synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy","volume":"132","author":"Ettle","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01287-8_bib98","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mds.27562","article-title":"Anle138b modulates \u03b1-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy","volume":"34","author":"Heras-Garvin","year":"2019","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40035-020-00217-y","article-title":"Targeting \u03b1-synuclein by PD03 AFFITOPE\u00ae and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance","volume":"9","author":"Lemos","year":"2020","journal-title":"Translational neurodegeneration"},{"key":"10.1007\/s13311-022-01287-8_bib100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-015-0008-9","article-title":"Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy","volume":"10","author":"Mandler","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-022-01287-8_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.07.007","article-title":"The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent alpha-synuclein in experimental multiple system atrophy","author":"Herrera-Vaquero","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1007\/s13311-022-01287-8_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28714","article-title":"ATH434 reduces \u03b1-synuclein-related neurodegeneration in a murine model of multiple system atrophy","author":"Heras-Garvin","year":"2021","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib103","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1073\/pnas.1609291113","article-title":"Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy","volume":"113","author":"Bassil","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01287-8_bib104","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/WNR.0b013e32830b3661","article-title":"Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy","volume":"19","author":"Ubhi","year":"2008","journal-title":"NeuroReport"},{"key":"10.1007\/s13311-022-01287-8_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105509","article-title":"Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy","volume":"159","author":"Shukla","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-022-01287-8_bib106","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12640-015-9547-7","article-title":"Failure of neuroprotection despite microglial suppression by delayed-start myeloperoxidase inhibition in a model of advanced multiple system atrophy: clinical implications","volume":"28","author":"Kaindlstorfer","year":"2015","journal-title":"Neurotox Res"},{"key":"10.1007\/s13311-022-01287-8_bib107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-017-0195-7","article-title":"Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal alpha-synucleinopathy","volume":"12","author":"Venezia","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-022-01287-8_bib108","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","article-title":"Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors","volume":"30","author":"Ubhi","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-022-01287-8_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awx044","article-title":"Insulin resistance and exendin-4 treatment for multiple system atrophy","author":"Bassil","year":"2017","journal-title":"Brain"},{"key":"10.1007\/s13311-022-01287-8_bib110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s13311-016-0447-1","article-title":"Neuroprotection by epigenetic modulation in a transgenic model of multiple system atrophy","volume":"13","author":"Sturm","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-022-01287-8_bib111","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/mds.28847","article-title":"Neurofilament light chain predicts disease severity and progression in multiple system atrophy","volume":"37","author":"Zhang","year":"2022","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-022-01287-8_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019808","article-title":"Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection","volume":"6","author":"Stemberger","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01287-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:34:34Z","timestamp":1761806074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1878747923001095"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01287-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Mouse Model of Multiple System Atrophy: Bench to Bedside","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01287-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}